Drug-Induced Hepatotoxicity
The DOI matches its Crossref record; 182 of the 182 references it cites were found in a registry or an index.
Abstract
Drug-induced hepatic injury accounts for more than 50 percent of cases of acute liver failure in the United States. More than 75 percent of idiosyncratic drug reactions result in liver transplantation or death. This review discusses the pathogenesis of drug-induced liver injury, common adverse drug reactions involving the liver, and the drug-approval process. Monitoring for and recognition of drug-induced hepatotoxicity may prevent some cases of acute hepatic failure.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is known that many variables, such as genetic variability, race, sex, age, metabolic capacity, drug-drug interactions, and preexisting diseases, contribute to individual susceptibility and toxicity of idiosyncratic drugs (Lee, 2003).”
From Mitochondrial Dysfunction Induced by Sertraline, an Antidepressant Agent (2012) · cites this paper as Lee, 2003
In the citing paper
“Under these limited conditions, two-dimensional (2D) monolayered cells exhibit altered biological features, including morphology, function, hepatic polarity, and genotype expression (Lasser et al., 2002;Lee, 2003;Ma et al., 2023).”
From Fast formation and maturation enhancement of human liver organoids using a liver-organoid-on-a-chip (2024) · cites this paper as Lee, 2003
Citations
Cites
Incidence of Adverse Drug Reactions in Hospitalized Patients: A Meta-analysis of Prospective Studies
Lazarou, J., Pomeranz, B. H., & Corey, P. N. (1998) · JAMA · doi:10.1001/jama.279.15.1200 · Cited by 4,807
Ostapowicz, G., Fontana, R. J., Schiødt, F. V., Larson, A., Davern, T. J., Han, S. H. B., McCashland, T. M., Shakil, A. O., Hay, J. E., Hynan, L., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-12-200212170-00007 · Cited by 2,227
Self-citationEarly indicators of prognosis in fulminant hepatic failure
O'Grady, J. G., Alexander, G. J. M., Hayllar, K. M., & Williams, R. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)90081-4 · Cited by 2,085
ACETAMINOPHEN-INDUCED HEPATIC NECROSIS. IV. PROTECTIVE ROLE OF GLUTATHIONE
Mitchell, J. R., Jollow, D. J., Potter, W. Z., Gillette, J. R., & Brodie, B. B. (1973) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29666-5 · Cited by 1,737
Role of Quinones in Toxicology
Bolton, J. L., Trush, M. A., Penning, T. M., Dryhurst, G., & Monks, T. J. (2000) · Chemical Research in Toxicology · doi:10.1021/tx9902082 · Cited by 1,703
Common and Uncommon Cytochrome P450 Reactions Related to Metabolism and Chemical Toxicity
Guengerich, F. P. (2001) · Chemical Research in Toxicology · doi:10.1021/tx0002583 · Cited by 1,655
Danan, G., & Benichou, C. (1993) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(93)90101-6 · Cited by 1,481
Jaeschke, H. (2002) · Toxicological Sciences · doi:10.1093/toxsci/65.2.166 · Cited by 1,304
McDonald, G. B., Hinds, M. S., Fisher, L. D., Schoch, H. G., Wolford, J. L., Banaji, M., Hardin, B. J., Shulman, H. M., & Clift, R. A. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-4-199302150-00003 · Cited by 1,202
Efficacy of Oral N-Acetylcysteine in the Treatment of Acetaminophen Overdose
Smilkstein, M. J., Knapp, G. L., Kulig, K. W., & Rumack, B. H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198812153192401 · Cited by 1,102
Research works printed but not linked: 9
- Yun CH, 1993, Drug Metab Dispos, 21, 403
- Chitturi S, 2001, Semin Gastrointest Dis, 12, 113
- Wang K, 1999, Zhonghua Yi Xue Za Zhi (Taipei), 62, 369
- George J, 1995, Hepatology, 21, 120
- Meadows M, 2001, FDA Consum, 35, 8
- Piliero PJ, 2001, AIDS Read, 11, 379
- 10.1111/j.1572-0241.1999.01091.x · doi:10.1111/j.1572-0241.1999.01091.x · Paper page
- Fernandes NF, 2000, Am J Gastroenterol, 95, 532, 10.1111/j.1572-0241.2000.t01-1-01780.x · doi:10.1111/j.1572-0241.2000.t01-1-01780.x · Paper page
- Graham DJ, 2002, Hepatology, 36, 168A
Cited by
Items 401–500 of 1,000
Thomas, M. G., Marwood, R. M., Parsons, A. E., & Parsons, R. B. (2015) · Toxicology in Vitro · doi:10.1016/j.tiv.2015.10.007 · Cited by 52
Palmatine ameliorates nephrotoxicity and hepatotoxicity induced by gentamicin in rats
Khaksari, M., Esmaili, S., Abedloo, R., & Khastar, H. (2019) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2019.1633354 · Cited by 51
Bioprinting of Human Liver‐Derived Epithelial Organoids for Toxicity Studies
Bouwmeester, M. C., Bernal, P. N., Oosterhoff, L. A., van Wolferen, M. E., Lehmann, V., Vermaas, M., Buchholz, M., Peiffer, Q. C., Malda, J., van der Laan, L. J. W., et al. (2021) · Macromolecular Bioscience · doi:10.1002/mabi.202100327 · Cited by 46
The Use of Hepatocytes to Investigate Drug Toxicity
Gómez-Lechón, M. J., Castell, J. V., & Donato, M. T. (2010) · Methods in Molecular Biology · doi:10.1007/978-1-60761-688-7_21 · Cited by 51
WATANABE, M. (2004) · Hepatology Research · doi:10.1016/j.hepres.2004.08.005 · Cited by 44
Drug-Induced Hepatotoxicity or Drug-Induced Liver Injury
Pugh, A. J., Barve, A. J., Falkner, K. C., Patel, M., & McClain, C. J. (2009) · Clinics in Liver Disease · doi:10.1016/j.cld.2009.02.008 · Cited by 56
Beneficial effect of corticosteroids for patients with severe drug‐induced liver injury
Hu, P. F., Wang, P. Q., Chen, H., Hu, X. F., Xie, Q. P., Shi, J., Lin, L., & Xie, W. F. (2016) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12383 · Cited by 50
Human drug hepatotoxicity: a contemporary clinical perspective
Assis, D. N., & Navarro, V. J. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250902927386 · Cited by 50
Kenne, K., Skånberg, I., Glinghammar, B., Berson, A., Pessayre, D., Flinois, J.-P., Beaune, P. H., Edebert, I., Pohl, C. D., Carlsson, S., et al. (2007) · Toxicology in Vitro · doi:10.1016/j.tiv.2007.11.014 · Cited by 52
Anticoagulants and Transaminase Elevation
Arora, N., & Goldhaber, S. Z. (2006) · Circulation · doi:10.1161/circulationaha.105.603100 · Cited by 50
Creating an effective clinical registry for rare diseases
D‘Agnolo, H. M. A., Kievit, W., Andrade, R. J., Karlsen, T. H., Wedemeyer, H. H., & Drenth, J. P. H. (2015) · United European Gastroenterology Journal · doi:10.1177/2050640615618042 · Cited by 53
Pachkoria, K., Lucena, M. I., Ruiz‐Cabello, F., Crespo, E., Cabello, M. R., Andrade, R. J., & on behalf of the Spanish Group for the Study of Drug‐Induced Liver Disease (Grupo de Estudio para las Hepatopatías Asociadas a Medicamentos (GEHAM) (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707122 · Cited by 49
Acute hepatitis due to buprenorphine administration
Herv, S., Riachi, G., Noblet, C., Guillement, N., Tanasescu, S., Goria, O., Thuillez, C., Tranvouez, J. L., Ducrotte, P. R., & Lerebours, É. (2004) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200410000-00013 · Cited by 51
Prot, J. M., Briffaut, A.-S., Letourneur, F., Chafey, P., Merlier, F., Grandvalet, Y., Legallais, C., & Leclerc, É. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021268 · Cited by 49
Severe Pazopanib-Induced Hepatotoxicity: Clinical and Histologic Course in Two Patients
Klempner, S. J., Choueiri, T. K., Yee, E. U., Doyle, L. A., Schuppan, D., & Atkins, M. B. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.41.0332 · Cited by 49
Is Incretin-Based Therapy Ready for the Care of Hospitalized Patients With Type 2 Diabetes?
Umpierrez, G. E., & Korytkowski, M. (2013) · Diabetes Care · doi:10.2337/dc12-2233 · Cited by 49
Characterization and reproducibility of HepG2 hanging drop spheroids toxicology in vitro
Hurrell, T., Ellero, A. A., Masso, Z. F., & Cromarty, D. (2018) · Toxicology in Vitro · doi:10.1016/j.tiv.2018.02.013 · Cited by 52
Ouyang, D. W., Shapiro, D. E., Lü, M., Brogly, S. B., French, A. L., Leighty, R. M., Thompson, B., TUOMALA, R. E., & Hershow, R. C. (2009) · AIDS · doi:10.1097/qad.0b013e32832e34b1 · Cited by 48
Enbom, E. T., Le, M. D., Oesterich, L. G., Rutgers, J. K. L., & French, S. W. (2014) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2014.03.003 · Cited by 48
The controvertible role of kava (Piper methysticum G. Foster) an anxiolytic herb, on toxic hepatitis
Amorim, M. F. D., Diniz, M. D. F. F. M., de Araújo, M. S. T., Pita, J. C. L. R., Dantas, J. G., Ramalho, J. D. A., Xavier, A. L., Palomaro, T. V., & Júnior, N. L. B. (2007) · Revista Brasileira de Farmacognosia · doi:10.1590/s0102-695x2007000300020 · Cited by 61
Meharie, B. G., Amare, G. G., & Belayneh, Y. M. (2020) · Journal of Experimental Pharmacology · doi:10.2147/jep.s248677 · Cited by 56
Evaluation of prognostic markers in severe drug-induced liver disease
Li, B. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i4.628 · Cited by 48
Hussan, F., Mansor, A. S., Hassan, S. N., Kamaruddin, T. N. T. T. N. E., Budin, S. B., & Othman, F. B. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/347861 · Cited by 48
Smet, P. A. G. M. D., Denneboom, W., Kramers, C., & Grol, R. P. T. M. (2007) · Drugs & Aging · doi:10.2165/00002512-200724090-00003 · Cited by 59
Emerging In Vitro Liver Technologies for Drug Metabolism and Inter-Organ Interactions
Bale, S. S., Moore, L., Yarmush, M., & Jindal, R. (2016) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2016.0031 · Cited by 46
Alachkar, H., Fulton, N. C., Sanford, B. L., Malnassy, G., Mutonga, M., Larson, R. A., Bloomfield, C. D., Marcucci, G., Nakamura, Y., & Stock, W. (2016) · The Pharmacogenomics Journal · doi:10.1038/tpj.2016.7 · Cited by 54
Sestrin2 protects against acetaminophen-induced liver injury
Kim, S. J., Kim, K. M., Yang, J. H., Cho, S. S., Kim, J. Y., Park, S. J., Lee, S., Ku, S., Cho, I. J., & Ki, S. H. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.02.002 · Cited by 48
Recent Advances Using Immunomodulators for Inflammatory Bowel Disease
Nielsen, O. H., Bjerrum, J. T., Herfarth, H. H., & Rogler, G. (2013) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.2 · Cited by 47
Lotz, O., McKenzie, D. R., Bilek, M., & Akhavan, B. (2023) · Progress in Materials Science · doi:10.1016/j.pmatsci.2023.101124 · Cited by 46
Anderson, N., & Borlak, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025221 · Cited by 48
Risk of liver toxicity with the angiogenesis inhibitor pazopanib in cancer patients
Kapadia, S., Hapani, S., Choueiri, T. K., & Wu, S. (2013) · Acta Oncologica · doi:10.3109/0284186x.2013.782103 · Cited by 46
Hepatotoxicity induced by cyproterone acetate: A report of three cases
Savidou, I. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i46.7551 · Cited by 46
Gao, Y., Cao, Z., Yang, X., Abdelmegeed, M. A., Sun, J., Chen, S., Beger, R. D., Davis, K. J., Salminen, W. F., Song, B., et al. (2016) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201600123 · Cited by 49
da Silva, V. D., de Faria, B. M., COLOMBO, E. H. F., Ascari, L. M., de Freitas, G. P. A., Flôres, L. S., Cordeiro, Y., Romão, L. F., & Buarque, C. D. (2018) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2018.10.003 · Cited by 46
Cholestatic liver injury induced by food additives, dietary supplements and parenteral nutrition
Vilas‐Boas, V., Gijbels, E., Jonckheer, J., Waele, E. D., & Vinken, M. (2019) · Environment International · doi:10.1016/j.envint.2019.105422 · Cited by 47
Highly Sensitive Two-Photon Lipid Droplet Tracker for In Vivo Screening of Drug Induced Liver Injury
Lee, H. W., Lee, I.-J., Lee, S., Kim, Y. R., & Kim, H. M. (2022) · ACS Sensors · doi:10.1021/acssensors.1c02679 · Cited by 47
Obogwu, M. B., Akindele, A. J., & Adeyemi, O. O. (2014) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(14)60054-6 · Cited by 51
Zabana, Y., Domènech, E., López–Sanromán, A., Beltrán, B., Cabriada, J. L., Saro, C. M., Araméndiz, R., Ginard, D., Hinojosa, J., Gisbert, J. P., et al. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20496 · Cited by 46
Preventive care in chronic liver disease
Riley, T., & Smith, J. P. (1999) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.1999.11188.x · Cited by 48
Effect of antiepileptic drugs on liver enzymes
Hussein, R. R. S., Soliman, R. H., Ali, A. M. A., Tawfeik, M. H., & Abdelrahim, M. E. A. (2013) · Beni-Suef University Journal of Basic and Applied Sciences · doi:10.1016/j.bjbas.2013.09.002 · Cited by 46
Iwamura, A., Fukami, T., Hosomi, H., Nakajima, M., & Yokoi, T. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.037259 · Cited by 48
Methylprednisolone-Induced Toxic Hepatitis
Topal, F., Özaslan, E., Akbulut, S., Küçükazman, M., Yüksel, O., & Altıparmak, E. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1h171 · Cited by 46
Review: Hepatic Steatosis and HIV Infection
Ristig, M. B., Drechsler, H., & Powderly, W. G. (2005) · AIDS Patient Care and STDs · doi:10.1089/apc.2005.19.356 · Cited by 51
Integrating multiple omics to unravel mechanisms of Cyclosporin A induced hepatotoxicity in vitro
den Hof, W. F. P. M. V., Ruiz‐Aracama, A., Summeren, A. V., Jennen, D. G. J., Gaj, S., Coonen, M. L. J., Brauers, K. J. J., Wodzig, W. K. W. H., van Delft, J. H. M., & Kleinjans, J. C. S. (2015) · Toxicology in Vitro · doi:10.1016/j.tiv.2014.12.016 · Cited by 47
Visioli, G., Marmiroli, M., & Marmiroli, N. (2010) · BioMed Research International · doi:10.1155/2010/567510 · Cited by 45
Tobwala, S., Khayyat, A. N., Fan, W., & Ercal, N. (2014) · Experimental Biology and Medicine · doi:10.1177/1535370214549520 · Cited by 49
Mechanisms of hepatotoxicity associated with the monocyclic β-lactam antibiotic BAL30072
Paech, F., Messner, S., Spickermann, J., Wind, M., Schmitt-Hoffmann, A.-H., Witschi, A. T., Howell, B. A., Church, R. J., Woodhead, J., Engelhardt, M. F., et al. (2017) · Archives of Toxicology · doi:10.1007/s00204-017-1994-x · Cited by 50
Pre-Existing Liver Disease and Toxicity of Antifungals
Spernovasilis, N. A., & Kofteridis, D. P. (2018) · Journal of Fungi · doi:10.3390/jof4040133 · Cited by 50
Expression and Function of TRP Channels in Liver Cells
Rychkov, G. Y., & Barritt, G. J. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-0265-3_35 · Cited by 60
Possible metformin-induced hepatotoxicity
Kutoh, E. (2005) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2005.12.002 · Cited by 45
A Consensus Statement for Safety Monitoring Guidelines of Treatments for Major Depressive Disorder
Dodd, S., Malhi, G. S., Tiller, J., Schweitzer, I., Hickie, I., Khoo, J. P., Bassett, D. L., Lyndon, B., Mitchell, P. B., Parker, G., et al. (2011) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048674.2011.595686 · Cited by 45
Drug-induced liver injury in older adults
Mitchell, S. J., & Hilmer, S. N. (2010) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098610386281 · Cited by 55
Gore, R. M. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-2332-6.50096-8 · Cited by 45
French, J. A. (1999) · Epilepsia · doi:10.1111/j.1528-1157.1999.tb00914.x · Cited by 45
Postoperative jaundice and total parenteral nutrition-associated hepatic dysfunction
Chung, C., & Buchman, A. L. (2002) · Clinics in Liver Disease · doi:10.1016/s1089-3261(02)00057-0 · Cited by 46
Chen, S., Wu, Q., Li, X., Li, D., Mei, N., Ning, B., Puig, M., Ren, Z., Tolleson, W. H., & Guo, L. (2021) · Journal of Environmental Science and Health, Part C · doi:10.1080/26896583.2021.1880242 · Cited by 44
Precision-cut organ slices to investigate target organ injury
Vickers, A. E. M., & Fisher, R. L. (2005) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.1.4.687 · Cited by 44
Regulatory causality evaluation methods applied in kava hepatotoxicity: Are they appropriate?
Teschke, R., & Wolff, A. (2010) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2010.09.006 · Cited by 44
Herb induced liver injury after using herbal medicine: A systemic review and case-control study
Lin, N.-H., Yang, H.-W., Su, Y.-J., & Chang, C.-W. (2019) · Medicine · doi:10.1097/md.0000000000014992 · Cited by 43
Mahesh, A., Shaheetha, J., Thangadurai, D., & Rao, D. M. (2009) · Biologia · doi:10.2478/s11756-009-0205-5 · Cited by 44
Subacute toxicopathological studies of methotrexate in Wistar rats
Patel, N. N., Ghodasara, D. J., Pandey, S., Ghodasara, P. D., Khorajiya, J. H., Joshi, B. P., & Dave, C. J. (2014) · Veterinary World · doi:10.14202/vetworld.2014.489-495 · Cited by 44
Knight, J. A. (2005) · Journal of Infusion Nursing · doi:10.1097/00129804-200503000-00004 · Cited by 44
Yun, J.-W., Kim, Y. K., Lee, B., Kim, C.-W., Hyun, J.-S., Baik, J.-H., Kim, J., & Kim, B.-H. (2007) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.70403 · Cited by 43
Gómez-Lechón, M. J., Tolosa, L., Castell, J. V., & Donato, M. T. (2010) · Toxicology in Vitro · doi:10.1016/j.tiv.2010.07.018 · Cited by 44
Hee, D. K.-H., Seo, J. J., & Lee, L. (2014) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2014.09.019 · Cited by 43
SARS-CoV-2 Infection and the Liver
Morgan, K., Samuel, K., Vandeputte, M., Hayes, P. C., & Plevris, J. N. (2020) · Pathogens · doi:10.3390/pathogens9060430 · Cited by 43
the Homeobox Gene Hex Regulates Hepatocyte Differentiation From Embryonic Stem Cell–Derived Endoderm
Kubo, A., Kim, Y. H., Irion, S., Kasuda, S., Takeuchi, M., Ohashi, K., Iwano, M., Dohi, Y., Saito, Y., Snodgrass, R., et al. (2009) · Hepatology · doi:10.1002/hep.23293 · Cited by 46
Hospital Admissions for Drug-Induced Liver Injury: Clinical Features, Therapy, and Outcomes
Hou, F.-Q., Zeng, Z., & Wang, G. (2012) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-012-9373-y · Cited by 48
Coffin, C. S., Fraser, H. F., Panaccione, R., & Ghosh, S. K. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21336 · Cited by 42
Petri, N., Bergman, E., Forsell, P., Hedeland, M., Bondesson, U., Knutson, L., & Lennernäs, H. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.008409 · Cited by 42
In Vitro Models of the Liver: Disease Modeling, Drug Discovery and Clinical Applications
Collins, S. D., Yuen, G., Tu, T., Budzinska, M. A., Spring, K. J., Bryant, K., & Shackel, N. A. (2019) · Codon Publications eBooks · doi:10.15586/hepatocellularcarcinoma.2019.ch3 · Cited by 57
Use of thiopurines in inflammatory bowel disease
Frei, P. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i7.1040 · Cited by 42
Ornidazole‐induced liver damage: report of three cases and review of the literature
Tabak, F., Özaras, R., Erzin, Y. Z., Çelık, A. F., Özbay, G., & Şentürk, H. (2003) · Liver International · doi:10.1034/j.1478-3231.2003.00860.x · Cited by 41
Case Report: Fulminant Hepatic Failure Involving Duloxetine Hydrochloride
Hanje, A. J., Pell, L. J., Votolato, N. A., Frankel, W. L., & Kirkpatrick, R. B. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.04.018 · Cited by 44
Luo, Y., Rana, P., & Will, Y. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfs208 · Cited by 42
Knowledge of appropriate acetaminophen doses and potential toxicities in an adult clinic population
Stumpf, J. L., Skyles, A. J., Alaniz, C., & Erickson, S. R. (2007) · Journal of the American Pharmacists Association · doi:10.1331/1544-3191.47.1.35.stumpf · Cited by 45
Elevated levels of circulating CDH5 and FABP1 in association with human drug‐induced liver injury
Mikus, M., Drobin, K., Gry, M., Bachmann, J., Lindberg, J., Yimer, G., Aklillu, E., Makonnen, E., Aderaye, G., Roach, J., et al. (2017) · Liver International · doi:10.1111/liv.13174 · Cited by 40
Hepatotoxicity and metabolism of trabectedin: a literature review
Beumer, J. H., Schellens, J. H. M., & Beijnen, J. H. (2005) · Pharmacological Research · doi:10.1016/j.phrs.2004.12.001 · Cited by 42
Mechanisms of tolvaptan-induced toxicity in HepG2 cells
Wu, Y., Beland, F. A., Chen, S., Liu, F., Guo, L., & Fang, J.-L. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.03.015 · Cited by 41
Mapping the incidence of drug‐induced liver injury: A systematic review and meta‐analysis
Li, M., Wang, Y., Lv, T. T., Liu, J. M., Kong, Y. Y., Jia, J. D., & Zhao, X. Y. (2023) · Journal of Digestive Diseases · doi:10.1111/1751-2980.13205 · Cited by 39
Iida, A., Sasaki, E., Yano, A., Tsuneyama, K., Fukami, T., Nakajima, M., & Yokoi, T. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.063370 · Cited by 41
Sheng, Y., Wu, G., He, H., Chen, W., Zou, Y., Li, Q., Zhong, L., Huang, Y., & Deng, C. (2014) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2014.01.034 · Cited by 41
Safety of Anti-Tumor Necrosis Factor Therapies in Arthritis Patients
Nanau, R. M., & Neuman, M. G. (2014) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3wp4f · Cited by 44
Models of Idiosyncratic Drug-Induced Liver Injury
Yokoi, T., & Oda, S. (2021) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-030220-015007 · Cited by 38
High-Content Screening for the Detection of Drug-Induced Oxidative Stress in Liver Cells
Donato, M. T., & Tolosa, L. (2021) · Antioxidants · doi:10.3390/antiox10010106 · Cited by 45
Wang, P., Kaneko, T., Wang, Y., & Sato, A. (1999) · Hepatology · doi:10.1002/hep.510290109 · Cited by 44
Systemic Therapy for Hepatocellular Carcinoma
Thomas, M. B. (2008) · The Cancer Journal · doi:10.1097/ppo.0b013e31816a6058 · Cited by 43
Le, T. T., Ziemba, A. J., Urasaki, Y., Brotman, S. J., & Pizzorno, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051092 · Cited by 44
Hepatotoxicity induced by clozapine: a case report and review of literature
Wu, Lu, M., & Shen, W. W. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s67654 · Cited by 42
A problem-oriented approach to liver disease in oncology patients
McDonald, G. B., & Frieze, D. A. (2008) · Gut · doi:10.1136/gut.2007.131136 · Cited by 41
Riley, T., & Bhatti, A. (2001) · PubMed · Cited by 41
Mandenius, C., Andersson, T. B., Alves, P. M., Batzl‐Hartmann, C., Björquist, P., Carrondo, M. J. T., Chesné, C., Coecke, S., Edsbagge, J., Fredriksson, J. M., et al. (2011) · Alternatives to Laboratory Animals · doi:10.1177/026119291103900210 · Cited by 49
Liver enzyme abnormalities in systemic lupus erythematosus: a focus on toxic hepatitis
Her, M., Lee, Y., Jung, E. U., Kim, T. H., & Kim, D. (2009) · Rheumatology International · doi:10.1007/s00296-009-1237-4 · Cited by 43
Khan, R. A., Khan, M. R., Ahmed, M., Sahreen, S., Shah, N. A., Shah, M. S., Bokhari, J., Rashid, U., Ahmad, B., & Jan, S. (2012) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-12-114 · Cited by 40
The Characteristics and Clinical Outcome of Drug-induced Liver Injury: A Single-center Experience
Idilman, R., Bektas, M., Cnar, K., Toruner, M., Cerit, E. T., Doganay, B., Erden, E., Bozkaya, H., Bahar, K., Karayalcin, S., et al. (2010) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3181c5e9cc · Cited by 40
Steroid Therapy for a Case of Severe Drug-Induced Cholestasis
Giannattasio, A., D'ambrosi, M., Volpicelli, M., & Iorio, R. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1g345 · Cited by 40
Effect of tetracycline on pancreas and liver function of adult male albino rats
Asha, K. K., Sankar, T. V., & Nair, P. (2007) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.59.9.0008 · Cited by 40
Hepatitis aguda por ingestión de infusiones con Teucrium chamaedrys
Álvarez, J. C. P., Sáez-Royuela, F., Peña, E. G., Morante, A., Lorente, J. L. M., & Oses, A. V. (2001) · Gastroenterología y Hepatología · doi:10.1016/s0210-5705(01)70162-8 · Cited by 40
EVALUATION OF ABNORMAL LIVER FUNCTION TESTS
Moseley, R. H. (1996) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70472-7 · Cited by 40
Zoulim, F. (1999) · Antiviral Research · doi:10.1016/s0166-3542(99)00056-x · Cited by 40
Metadata
- Authors
- Lee, W. M.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Lee, William M.
- ORCID
- Lee, William M.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-07-31
- Volume
- 349
- Issue
- 5
- Pages
- 474-485
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W3021092633
- Cited by
- 1,594
- References
- 180
- Citations by year
- 2026: 15 · 2025: 14 · 2024: 33 · 2023: 41 · 2022: 44 · 2021: 44 · 2020: 53 · 2019: 69 · 2018: 69 · 2017: 75 · 2016: 84 · 2015: 74 · 2014: 95 · 2013: 88 · 2012: 88
- FWCI
- 5.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Keywords
- drug-induced liver injury, acute liver failure, idiosyncratic drug reactions, adverse drug reactions, drug approval, hepatotoxicity monitoring, liver transplantation
- MeSH terms
- Troglitazone, Anti-Inflammatory Agents, Non-Steroidal, Benzophenones, Bromobenzenes, Chromans, Pharmaceutical Preparations, Humans, Hypoglycemic Agents, Liver, Liver Cirrhosis, Liver Diseases, Liver Function Tests, Pharmacology, Thiazoles, Drug Approval, Thiazolidinediones, Chemical and Drug Induced Liver Injury, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.